Increased expression of Bcl-2 pro-survival factors like MCL1 and BCLxL have previously been described as resistance mechanisms to ccRCC SoC agents like TKIs, and mTORCi (34, 35). Here, BCL2L1 is linked to nonpapillary renal cell carcinoma.